• Cognitive function
• Cerebrovascular disorders
• Hearing function
• Kidney function
• Eye health
Serving Size: 1 Capsule... %DV
Vinpocetine (from Voacanga africana seed)... 15 mg... †
† Daily Value not established
What Is It?
Vinpocetine is a modified compound originally found in the periwinkle plant (Vinca minor). Vinpocetine is an approved pharmaceutical treatment in Europe used for brain health and circulation, and age-associated cognitive impairment. Vinpocetine's effects are similar to those of Ginkgo biloba but with several additional benefits.
What Does It Do?Primary Uses: Vinpocetine helps support brain function and cognitive health. Like Ginkgo, vinpocetine supports blood flow, oxygen and nutrient delivery to the brain; unlike Ginkgo, it does so without reducing blood flow elsewhere in the body. Studies in red blood cells and damaged neurons show that vinpocetine directly increases ATP levels in these cells, supporting optimal brain energy levels. In addition, vinpocetine's blood thinning effects are far less potent than those of Ginkgo.
Secondary Uses: One study showed that vinpocetine helped reduce tinnitus and hearing loss after exposure to loud noises, and research suggests that it may also enhance circulation in the eyes.
Who Should Take It?
Vinpo-15 is an excellent alternative for those supplementing with Ginkgo biloba, especially for those concerned with its blood thinning effects. Vinpo-15 is a good choice for those looking to support their memory and brain function with age, as well as those with a family history of stroke. People chronically exposed to loud noises may also benefit from supplementing with vinpocetine.
Take 1-3 capsules daily with food, or as directed by a qualified health care practitioner. Increase dosage gradually.
CAUTION: Do not take if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking blood thinners, if you have high or low blood pressure, cardiac arrhythmia, dementia, or have suffered a stroke. Hypersensitivity is known to occur, and some people may experience anxiety, gastrointestinal discomfort, dizziness or headaches, in which case, discontinue use.
Afon'kin VIu, Dobretsov KG, Sipkin AV. [The new scheme of cavinton application to the treatment of chronic neurosensory loss of hearing]. Vestn Otorinolaringol. 2009;(6):69-70.
Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc. 1987 May;35(5):425-30.
Chukanova EI. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"]. Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(12):49-52.
Fischhof PK, Moslinger-Gehmayr R, Herrmann WM, et al. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology. 1996;34(1):29-35.
Kahan A, Olah M. Use of ethyl apovincaminate in ophthalmological therapy. Arzneimittelforschung. 1976;26(10a):1969-72.
Kiss B, Karpati E. Mechanism of action of vinpocetine. Acta Pharm Hung. 1996 Sep;66(5):213-24.
Konopka W, Zalewski P, Olszewski J, et al. Treatment results of acoustic trauma. Otolaryngol Pol. 1997;51 Suppl 25:281-4.
Molnar P, Gaal L, Horvath C. The impairment of long-term potentiation in rats with medial septal lesion and its restoration by cognition enhancers. Neurobiology (Bp). 1994;2(3):255-66.
Nagy Z, Vargha P, Kov Á cs L, BÖnÖczk P. Meta-analysis of Cavinton. Praxis. 1988 Sep; 7(9):63-8.
Pliushko DG, Sobko EG. Drug therapy of initial open-angle glaucoma. Oftalmol Zh. 1989;(2):72-4.
Subhan Z, Hindmarch I. Psychopharmaco-logical effects of vinpocetine in normal healthy volunteers. Eur J Clin Pharmacol. 1985;28(5):567-71.
Ueyoshi A, Ota K. Clinical appraisal of vinpocetine for the removal of intractable tumoral calcinosis in haemodialysis patients with renal failure. J Int Med Res. 1992 Sep;20(5):435-43.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.